Atlas Trials

Effect of Semaglutide in Patients With Psoriasis and Obesity

Clinical trial NCT06937060 · RECRUITING

Trial details

NCT number
NCT06937060
Sponsor
The University of Hong Kong
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis (PsO)Obesity and Overweight
Start date
2025-03-20
Primary completion
2026-07-31
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.